Data as of Q4 2025 (Dec 31, 2025)

HighVista Strategies LLC

โ€ขCIK: 1335325โ€ขFiling: Q4 2025

**HighVista Strategies LLC** manages $388M across a diversified portfolio of 145 positions. The fund exhibits concentrated exposure, with top holdings including DBC at $23.6M and GPCR at $13.4M. Further significant allocations are directed toward COGT ($12.0M), VRDN ($11.6M), and ABVX ($9.7M). This structure suggests a tactical, high-conviction approach across multiple sectors.

Total AUM
$388.3M
QoQ Performance
-4.8%
Positions
145
Top 10 Concentration
28.1%
Latest Filing
Q4 2025

Top Holdings Allocation

DBC
DBC6.1%
GPCR3.5%
COGT3.1%
VRDN3.0%
ABVX2.5%
RVMD2.5%
PRAX2.0%
NUVL1.9%

๐Ÿ“ˆ Biggest Buys

TERN
TERNS PHARMACEUTICALS INC
NEW
1.8% of portfolio
MAZE
MAZE THERAPEUTICS INC
NEW
1.8% of portfolio
SLNO
SOLENO THERAPEUTICS INC
+622.3%
1.6% of portfolio
โ€”
PHARVARIS N V
NEW
1.2% of portfolio
STOK
STOKE THERAPEUTICS INC
NEW
0.9% of portfolio

๐Ÿ“‰ Biggest Sells

PRAX
PRAXIS PRECISION MEDICINES I
-72.8%
2.0% of portfolio
ABVX
ABIVAX SA
-60.9%
2.5% of portfolio
CDTX
CIDARA THERAPEUTICS INC
-67.7%
1.3% of portfolio
SNDK
SANDISK CORP
-90.8%
0.3% of portfolio
DBC
INVESCO DB COMMDY INDX TRCK
-26.4%
6.1% of portfolio

Sector Breakdown

Other92.2%
Technology3.8%
Consumer1.4%
Financial1.3%
Industrial0.6%
Utilities0.4%
Healthcare0.3%

๐Ÿšช Exited Positionssold since Q3 2025

2GH
MERUS N V
SOLD
$12.6M
AKRO
AKERO THERAPEUTICS INC
SOLD
$5.2M
XENE
XENON PHARMACEUTICALS INC
SOLD
$3.3M
AMD
ADVANCED MICRO DEVICES INC
SOLD
$2.8M
VERA
VERA THERAPEUTICS INC
SOLD
$2.6M
+31 more exited positions

Changes from Q3 2025

NEW33 new positions
โ†‘26 increased
โ†“86 decreased

Historical Filings

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023